Abstract
One of the most attractive areas of research in drug delivery is the design of nanomedicines consisting of nanosystems that are able to deliver drugs to the right place, at appropriate time. Natural polysaccharides, due to their outstanding merits, have received more and more attention in the field of drug delivery systems. In particular, polysaccharides seem to be the most promising materials in the preparation of nanometric carriers. The main goal of the present study was to investigate the potential of a recent generation of hybrid polysaccharide nanocarriers, composed of chitosan (CS) and an anionic cyclodextrin, carboxymethyl-β-cyclodextrin (CM-β-CD), for the encapsulation of a model drug, sulindac. CS and CM-β-CD were processed to nanoparticles (NPs) via the ionotropic gelation technique. The stoichiometric ratio between these two polymers was found to influence particle size and zeta potential. Decreasing CS:CM-β-CD ratio led to an increase in particle size and decrease in zeta potential. DSC and FTIR analyses confirmed formation of NPs and encapsulation of sulindac inside them. Release profiles indicate a continuous release of the drug throughout 24 h. However, the rate of release was more rapid during the first hours; about 55–90% of the drug being released after 3 h.
Similar content being viewed by others
References
Brigger, I., Dubernet, C., Couvreur, P.: Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev. 54(5), 631–651 (2002)
Panyam, J., Labhasetwar, V.: Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55(3), 329–347 (2003)
Lamprecht, A., et al.: Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J. Pharmacol. Exp. Ther. 299, 775–781 (2001)
Yang, Y.Y., et al.: Polymeric core-shell nanoparticles for therapeutics. Clin. Exp. Pharmacol. Physiol. 33(5–6), 557–562 (2006)
Liu, Z., et al.: Polysaccharides-based nanoparticles as drug delivery systems. Adv. Drug Deliv. Rev. 60, 1650–1662 (2008)
Couvreur, P., et al.: Nanoparticles: preparation and characterization. In: Benita, S. (ed.) Microencapsulation Methods and Industrial Application, pp. 183–211. Marcel Dekker, New York (1996)
Kreuter, J.: Nanoparticles: preparation and applications. In: Donbrow, M. (ed.) Microcapsules and Nanoparticles in Medicine and Pharmacy, pp. 125–142. CRC Press, Boca Raton (1992)
Thies, C.: A survey of microencapsulation processes. In: Benita, S. (ed.) Microencapsulation Methods and Industrial Applications, pp. 1–19. Marcel Dekker, New York (1996)
George, M., Abraham, T.E.: Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J. Control. Release 114, 1–14 (2006)
Muzzarelli, R.A.A.: Chitin, pp. 1–37. Pergamon Press, New York (1977)
Roberts, G.A.F.: Chitin Chemistry, vol. 1, pp. 274–315. The Mac Millan Press, London (1992)
Hamidi, M., Azadi, A., Rafiei, P.: Hydrogel nanoparticles in drug delivery. Adv. Drug Deliv. Rev. 60(15), 1638–1649 (2008)
Agnihortri, S.A., Mallikarjuna, N.N., Aminabhavi, T.M.: Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 100, 5–28 (2004)
Tiyaboonchai, W.: Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ. J. 11(3), 51–66 (2003)
Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017–1025 (1996)
Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743–1754 (1998)
Del Vallea, E.M.: Cyclodextrins and their uses: a review. Process Biochem. 39(9), 1033–1046 (2004)
Frömming, K.H., Szejtli, J.: Cyclodextrins in Pharmacy, Topics in Inclusion Science, pp. 413–444. Kluwer Academic Publishers, Dordrecht (1994)
Krauland, A.H., Alonso, M.J.: Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm. 340, 134–142 (2007)
Dollery, C.: Therapeutic Drugs, vol. 2, pp. S119–S122. Churchill Livingstone, London (1995)
Haanen, C.: Sulindac and its derivatives: A novel class of anticancer agents. Curr. Opin. Investig. Drugs 2(5), 677–683 (2001)
Higuchi, T., Connors, K.A.: Phase-solubility techniques. Adv. Anal. Chem. Instr. 4, 117–212 (1965)
Grenha, A., et al.: Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins. Eur. J. Pharm. Biopharm. 69, 83–93 (2008)
Grenha, A., et al.: Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Eur. J. Pharmaceut. Sci. 31, 73–84 (2007)
de Campos, A.M., et al.: Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharmaceut. Res. 21(5), 803–810 (2004)
Calvo, P., et al.: Novel hydrophilic chitosan–polyethylene oxide nanoparticles as protein carrier. J. Appl. Poly. Sci. 63, 125–132 (1997)
Maestrelli, F., et al.: A new drug nanocarrier system consisting of chitosan and hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Biopharm. 63, 79–86 (2006)
Trapani, A., Garcia-Fuentes, M., Alonso, M.J.: Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan. Nanotechnology 19, 1–10 (2008)
Csaba, N., Garcia-Fuentes, M., Alonso, M.J.: The performance of nanocarriers for transmucosal drug delivery. Expert Opin. 3, 463–478 (2006)
Crcarwvska, M.S., Dodov, M.G., Goracinova, K.: Chitosan coated Ca-alginate microparticles loaded with budenoside for delivery to the inflammed colonic mucosa. Eur. J. Pharm. Biopharm. 68, 565–578 (2008)
He, P., Davis, S.S., Illum, L.: In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166, 75–88 (1998)
Sinha, V.R., et al.: Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm. 274, 1–33 (2004)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ammar, H.O., El-Nahhas, S.A., Ghorab, M.M. et al. Chitosan/cyclodextrin nanoparticles as drug delivery system. J Incl Phenom Macrocycl Chem 72, 127–136 (2012). https://doi.org/10.1007/s10847-011-9950-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-011-9950-5